These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4436937)

  • 1. The role of serum dopamine-beta-hydroxylase in essential hypertension.
    Yashima O; Ozawa M; Sato M; Suzuki K; Kimura T
    Jpn Circ J; 1974 Dec; 38(12):1085-8. PubMed ID: 4436937
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of fusaric acid on urinary excretion of catecholamines: a clinical study with particular emphasis on the characteristics of its time-course change.
    Ozawa N
    Jpn Circ J; 1972 Nov; 36(11):1205-21. PubMed ID: 4678992
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum dopamine-beta-hydroxylase: a possible aid in the evaluation of hypertension.
    Schanberg SM; Stone RA; Kirshner N; Gunnells JC; Robinson RR
    Adv Biochem Psychopharmacol; 1974; 12(0):129-33. PubMed ID: 4608516
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension.
    Schanberg SM; Stone RA; Kirshner N; Gunnells JC; Robinson RR
    Science; 1974 Feb; 183(4124):523-5. PubMed ID: 4809562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of guanethidine upon the diurnal rhythm of cathecholamines, dopa and dopamine in patients with hypertension].
    Vishnepol'skiĭ IuIa
    Sov Med; 1969 Jan; 32(1):52-6. PubMed ID: 5385216
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopa, catecholamines and their metabolites in essential hypertension.
    Januszewicz W; Wocial B
    Clin Sci Mol Med Suppl; 1975 Jun; 2():295s-298s. PubMed ID: 1077780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of therapy for mild hypertension on circulating level of dopamine beta-hydroxylase.
    Grant C; Routh JI; Lawton W; Witte DL
    Clin Chim Acta; 1976 Jun; 69(2):333-40. PubMed ID: 1277563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental and clinical studies on the activity of human serum dopamine-beta-hydroxylase].
    Yashima O
    Nihon Naibunpi Gakkai Zasshi; 1973 Jan; 49(1):48-59. PubMed ID: 4734771
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary excretion of catecholamines and sodium and potassium levels in serum and erythrocytes in patients with renal hypertension].
    Midelauri BG
    Kardiologiia; 1967 Jul; 7(7):66-7. PubMed ID: 5607172
    [No Abstract]   [Full Text] [Related]  

  • 11. [Catecholamines metabolism in phenylketonuria].
    Bulakhova LO; Usherenko LS
    Fiziol Zh; 1973; 19(1):86-91. PubMed ID: 4690947
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of human serum dopamine -hydroxylase after the oral administration of fusaric acid.
    Nagatsu T; Kato T; Kuzuya H; Okada T; Umezawa H; Takeuchi T
    Experientia; 1972 Jul; 28(7):779-80. PubMed ID: 4658852
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of fusaric acid calcium on catecholamine metabolism and its clinical effects on essential hypertension].
    Ozawa M; Nakajima Y; Suzuki K; Sato T; Takahashi E
    Horumon To Rinsho; 1976 Jan; 24(1):79-86. PubMed ID: 942902
    [No Abstract]   [Full Text] [Related]  

  • 14. [Urinary excretion of catecholamines and their precursors in hypotensive patients].
    Frenkel' ID; Kalandarov SK; Studnitsina LA
    Kardiologiia; 1968 Jul; 8(7):71-3. PubMed ID: 5697488
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of a dopamine beta-hydroxylase inhibitor on tissue catecholamine levels in spontaneously hypertensive rats subjected to immobilization-cold stress.
    Ishi Y; Homma M; Yoshikawa A
    Neuropharmacology; 1975 Feb; 14(2):155-7. PubMed ID: 1153081
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum dopamine beta-hydroxylase activity in essential hypertension.
    Aoki K; Tazumi K; Yoshida T; Kato S; Sato I; Takikawa K
    Clin Sci Mol Med Suppl; 1976 Dec; 3():465S-467S. PubMed ID: 1071665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine-beta-hydroxylase activity and catecholamine concentrations in plasma: experimental and essential hypertension.
    Grobecker H; Saavedra JM; McCarty R; Chiueh CC; Kopin IJ
    Postgrad Med J; 1977; 53 Suppl 3():43-8. PubMed ID: 928266
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of dopamine beta-hydroxylase in blood vessels by picolinic acid derivatives in vivo and their anthypertensive effects.
    Hidaka H; Shoka F; Hashizume Y; Takemoto N; Yamamoto M
    Jpn J Pharmacol; 1975 Oct; 25(5):515-24. PubMed ID: 1221134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous fluorimetric determination of noradrenaline, adrenaline, dopamine and dopa (3,4- dihydroxyphenylalanine) in the urine].
    Valori C; Brunori CA; Renzini V; Porcellati C
    Ann Ist Super Sanita; 1971; 7(2):414-21. PubMed ID: 5155304
    [No Abstract]   [Full Text] [Related]  

  • 20. [Catecholamine metabolism in manic-depressive psychosis].
    Usherenko LS
    Fiziol Zh; 1970; 16(3):393-9. PubMed ID: 5509683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.